Analyst Reco. BioNTech SE BOERSE MUENCHEN

Equities

Real-time BOERSE MUENCHEN Other stock markets 06:00:48 2024-05-28 am EDT			5-day change	1st Jan Change
89.85 ^EUR	-0.17%		+7.02%	-5.40%

May. 24	European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower	MT
May. 24	BIONTECH : Deutsche Bank remains Neutral	ZD

BIONTECH : Deutsche Bank remains Neutral	May. 24	ZD
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	May. 17	MT
Evercore ISI Starts BioNTech With In Line Rating, $100 Price Target	May. 14	MT
BIONTECH : UBS remains Neutral	May. 10	ZD
HC Wainwright Raises BioNTech SE Price Target to $113 From $107, Maintains Buy Rating	May. 08	MT
BIONTECH : Deutsche Bank reaffirms its Neutral rating	May. 08	ZD
TD Cowen Adjusts BioNTech Price Target to $98 From $95, Maintains Hold Rating	May. 07	MT
BMO Capital Adjusts BioNTech Price Target to $122 From $123, Maintains Outperform Rating	May. 07	MT
BIONTECH : Goldman Sachs reiterates its Neutral rating	May. 07	ZD
BIONTECH : Jefferies gives a Neutral rating	May. 06	ZD
BIONTECH : Gets a Neutral rating from Deutsche Bank	Apr. 23	ZD
UBS Cuts BioNTech Price Target to $101 From $110, Maintains Neutral Rating	Mar. 27	MT
BIONTECH : Deutsche Bank remains Neutral	Mar. 22	ZD
TD Cowen Adjusts BioNTech Price Target to $95 From $101, Maintains Market Perform Rating	Mar. 21	MT
BIONTECH : A miss is a miss	Mar. 21
BIONTECH : Deutsche Bank reaffirms its Neutral rating	Mar. 21	ZD
BIONTECH : Goldman Sachs reiterates its Neutral rating	Mar. 21	ZD
BIONTECH : Jefferies sticks Neutral	Mar. 20	ZD
BIONTECH : UBS gives a Neutral rating	Mar. 20	ZD
BMO Capital Initiates Coverage on BioNTech With Outperform Rating, $127 Price Target	Feb. 23	MT

No results for this search

BIONTECH : A miss is a miss

March 21, 2024 at 09:27 am EDT